In vitro evaluation of 66 epidemiologically distinct, gentamicin-resistant, gram-negative isolates from four hospitals revealed that 92% were kanamycin resistant, 44% were netilmicin resistant, 41% were tobramycin resistant, and 6% were amikacin resistant. Combined resistance to gentamicin, tobramycin, and netilmicin occurred in 30% of the strains. Although the resistance percentage to amikacin was the lowest of the three newer agents, two strains were resistant to all of the aminoglycosides tested.
In recent years gentamicin-resistant, gramnegative bacteria have become more prevalent in hospitals (5, 6, 8, 10, 12, 13, 16 ). In the current study, gentamicin-resistant, gram-negative isolates from four different hospitals in New York City were tested for in vitro activity against one older aminoglycoside, kanamycin, and three newer aminoglycosides (tobramycin, netilmicin, and amikacin). All isolates were collected before any appreciable clinical use of tobramycin, netilmicin, or amikacin in these hospitals. Only epidemiologically distinct isolates from different patients were included.
In spite of numerous reports (1, 2, (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) 16) of in vitro susceptibility tests with the above antibiotics, comparatively little data have appeared which give the frequencies of resistance to other aminoglycosides in gentamicin-resistant strains. A strain with an MIC of >8 pg/ml was counted resistant to gentamicin, tobramycin, or netilmicin; however, because of the larger recommended doses of kanamycin and amikacin, 16 ,ug/ml was considered the highest sensitive MIC for these antibiotics. RESULTS In all test runs, the MICs for the susceptible control varied by no more than one dilution from the following median values (in micrograms per milliliter): gentamicin, 0.5; kanamycin, 2; tobramycin, 1; netilmicin, 1; amikacin, 1.
MATERIALS AND METHODS
A total of 66 isolates that met the criteria for being epidemiologically distinct, as defined above, were found to be gentamicin resistant (Table 1) . Isolates found to be susceptible by agar dilution were retested by disk diffusion. In all instances the disk tests indicated gentamicin susceptibility, usually with loss of resistance to other unrelated antibiotics, suggesting that the isolate had spontaneously lost an R factor during laboratory passage. Because the strains were not collected sequentially, the relative frequency of gentamicin resistance in different species is not necessarily indicated in the results. However, the sparcity of E. coli reflected the low frequency of gentamicin resistance in E. coli.
Isolates were obtained from 27 different wards of four hospitals (Table 2 ) and were collected between the last quarter of 1973 and the second quarter of 1976 ( (Table 4) . A total of 28% of the gentamicin-susceptible and 92% of the gentamicin-resistant isolates were kanamycin resistant. The MIC of kanamycin in five gentamicin-resistant, kanamycin-susceptible strains was 4 4,ug/ml. In the gentamicin-resistant strains, the distinction between susceptibility and resistance to the other aminoglycosides was less clear-cut. However, the 16-,ug/ml upper limit for amikacin susceptibility affected only one result, a strain of P. aeruginosa that was scored as susceptible to amikacin but resistant to the other aminoglycosides.
In all, 92% of these gentamicin-resistant isolates were kanamycin resistant, 44% were netilmicin resistant, 41% were tobramycin resistant, and 6% were amikacin resistant.
If 4 ,ug/ml had been chosen as the highest sensitive MIC for netilmicin and tobramycin, and 8 ,ug/ml had been chosen for amikacin, the resistance percentages for these antibiotics would have been increased to 70, 80, and 8%, respectively.
Resistance patterns revealed a considerable degree of cross resistance ( Table 5 ). The most common resistance pattern was gentamicinkanamycin; however, the second most common pattern was gentamicin-kanamycin-tobramycin-netilmicin. Two of the strains, a Pseudomonas not P. aeruginosa, and a S. marcescens, were resistant to all aminoglycosides. Fifteen isolates were susceptible only to amikacin, one isolate was susceptible only to tobramycin, and one isolate was susceptible only to kanamycin. DISCUSSION The criteria used for strain selection influence the estimation of resistance percentage. Many authors limit selection to one specimen of a given species per patient. If a particular institution is having an outbreak with a particular strain, that strain will distort the results. In the current study, no more than one isolate per ward was accepted within a 6-month period. Such a criterion diminishes the influence of an epidemic strain, but equates the isolate having little potential for epidemic spread with the isolate more capable of intrahospital spread.
The species selected for susceptibility testing affected the resistance percentages. Nonfermetative rods other than P. aeruginosa are especially likely to be amikacin resistant (10, 11) . Only three isolates belonged to this category, and two of them were amikacin resistant. Since such species are less virulent than the Enterobacteriaceae and P. aeruginosa, their relative infrequency in this series is appropriate.
The isolates were obtained before widespread use of tobramycin, netilmicin, or amikacin in the New York area; hence, the resistances observed reflected the selective pressure of kanamycin and gentamicin. As judged by an MIC >8 Ag/ml, resistance percentages to tobramycin and netilmicin in the gentamicin-resistant strains were high. The median MICs, however, in the tobramycin-and netilmicin-resistant isolates were relatively low, 16 and 32 ,g, compared to 128 and >128 ,ug/ml for gentamicin and kanamycin respectively. Since gentamicin resistance was a prerequisite for inclusion in the study, no strain was susceptible only to gentamicin; however, gentamicin-susceptible, tobramycin-netilmicin-amikacin-resistant strains have been described (7) .
The MICs of aminoglycosides for some bacteria, particularly P. aeruginosa, are lower when the concentrations of Mg and Ca ions are less than serum concentrations. The concentrations of these ions in Mueller-Hinton agar (but not broth) approximates physiological concentrations (2, 5, 7, 8) .
All of the antibiotics tested in this study were 4,6-diglycosylated 2-deoxystreptamine antibiotics. Eight enzymes produced by gram-negative bacteria are known to inactivate these antibiotics (11) . Of these enzymes, only one, an aminoglycoside acetyltransferase, AAC(6'), inactivates amikacin. Accordingly, the relatively low resistance percentage for amikacin is not surprising and is consistent with previous reports (1, 5, 8, 10, 11, 14) . However, some strains are resistant by mechanisms other than enzymatic inactivation. These strains are both resistant and relatively impermeable to all aminoglycosides (3, 11) .
With the emergence of gentamicin resistance, treatment strategies have become more complex. Since isolates may be susceptible only to kanamycin, tobramycin, or amikacin, routine clinical laboratory testing should include all these antibiotics, especially for the gentamicin-resistant strains.
At the time gentamicin was introduced into clinical use, gentamicin resistance in the common gram-negative pathogens was less than 1%. Accordingly, the potential for the emergence of more widespread resistance to the newer aminoglycosides is probably greater than the potential for emergence of gentamicin resistance when that antibiotic was first used. ACKNOWLEDGMENTS I thank Marcelino Sierra, Charles Cherubin, and Leona Caroline for providing gentamicin-resistant clinical isolates.
